BRPI0821386A2 - Processo para a preparação de r-lansoprazol amorfo estável - Google Patents

Processo para a preparação de r-lansoprazol amorfo estável

Info

Publication number
BRPI0821386A2
BRPI0821386A2 BRPI0821386-0A BRPI0821386A BRPI0821386A2 BR PI0821386 A2 BRPI0821386 A2 BR PI0821386A2 BR PI0821386 A BRPI0821386 A BR PI0821386A BR PI0821386 A2 BRPI0821386 A2 BR PI0821386A2
Authority
BR
Brazil
Prior art keywords
lansoprazole
preparation
stable amorphous
amorphous
stable
Prior art date
Application number
BRPI0821386-0A
Other languages
English (en)
Inventor
Samir Naik
Arjun Bodke
Kishor Mahajan
Manjunath Narayan Bhanu
Original Assignee
Watson Pharma Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Pharma Private Ltd filed Critical Watson Pharma Private Ltd
Publication of BRPI0821386A2 publication Critical patent/BRPI0821386A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0821386-0A 2007-12-18 2008-12-18 Processo para a preparação de r-lansoprazol amorfo estável BRPI0821386A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2489MU2007 2007-12-18
PCT/IN2008/000842 WO2009087672A1 (en) 2007-12-18 2008-12-18 A process for preparation of stable amorphous r-lansoprazole

Publications (1)

Publication Number Publication Date
BRPI0821386A2 true BRPI0821386A2 (pt) 2015-06-16

Family

ID=40651360

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821386-0A BRPI0821386A2 (pt) 2007-12-18 2008-12-18 Processo para a preparação de r-lansoprazol amorfo estável

Country Status (6)

Country Link
US (1) US20100280077A1 (pt)
EP (1) EP2222663A1 (pt)
AU (1) AU2008346115A1 (pt)
BR (1) BRPI0821386A2 (pt)
NZ (2) NZ593629A (pt)
WO (1) WO2009087672A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
EP2265605A4 (en) * 2008-03-18 2011-08-03 Reddys Lab Ltd Dr METHOD OF MANUFACTURING DEXLANSOPRAZOLE AND POLYMORPHIDE THEREOF
AU2009336561A1 (en) 2008-05-14 2010-07-15 Watson Pharma Private Limited Stable R-(+)-lansoprazole amine salt and a process for preparing the same
IT1391758B1 (it) * 2008-11-11 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo amorfo
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
WO2012095859A1 (en) * 2011-01-12 2012-07-19 Hetero Research Foundation Polymorphs of dexlansoprazole salts
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CN1117747C (zh) * 2000-06-19 2003-08-13 中国科学院成都有机化学研究所 光学纯兰索拉唑的制备方法
WO2002012225A1 (fr) * 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
HU229356B1 (en) * 2000-12-01 2013-11-28 Takeda Pharmaceutical Process for the crystallization of (r)- or (s)-lansoprazole
ES2286408T3 (es) * 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
ES2534713T3 (es) * 2002-10-16 2015-04-27 Takeda Pharmaceutical Company Limited Preparaciones sólidas estables
ES2259269B1 (es) * 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
AU2009336561A1 (en) * 2008-05-14 2010-07-15 Watson Pharma Private Limited Stable R-(+)-lansoprazole amine salt and a process for preparing the same

Also Published As

Publication number Publication date
EP2222663A1 (en) 2010-09-01
US20100280077A1 (en) 2010-11-04
WO2009087672A1 (en) 2009-07-16
NZ593629A (en) 2012-11-30
NZ585944A (en) 2011-11-25
AU2008346115A1 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BRPI0820733A2 (pt) Processo para a preparação de macrociclo
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
BRPI0810842A2 (pt) Processo para a carbonilação de dimetil éter
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI1015061A2 (pt) "processo para a preparação contínua de isocianatos"
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0810067A2 (pt) Processo para a preparação de capecitabina
BRPI0810817A2 (pt) Processo para a carbonilação de dimetil éter
BRPI1013561A8 (pt) processo para a preparação de alogliptina
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0810850A2 (pt) Processo para carbonilação de dimetil éter
BRPI0812422A2 (pt) Processo de preparação de um aldeído hidroxiaromático
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI1006679A2 (pt) "processo para a preparação de um composto de estireno halogenado"
BRPI0810846A2 (pt) Processo para carbonilção de dimetil éter
BRPI1010128A2 (pt) "processo para a fabricação do 2,3,3,3 - tetrafluropropeno"
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI0811644A2 (pt) Processo para a produção de pirazóis
BRPI0809652A2 (pt) Processo melhorado para a síntese de solifenacina
BRPI0915365A2 (pt) Processo para a preparação de 2-triflúor-metil-5-alquil-piridinas substituídas na posição 1
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI1013830A2 (pt) Processo para a iodação de compostos aromáticos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.